JPWO2022197758A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022197758A5 JPWO2022197758A5 JP2023557140A JP2023557140A JPWO2022197758A5 JP WO2022197758 A5 JPWO2022197758 A5 JP WO2022197758A5 JP 2023557140 A JP2023557140 A JP 2023557140A JP 2023557140 A JP2023557140 A JP 2023557140A JP WO2022197758 A5 JPWO2022197758 A5 JP WO2022197758A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- compound
- nitrogen
- sulfur
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162468P | 2021-03-17 | 2021-03-17 | |
| US63/162,468 | 2021-03-17 | ||
| PCT/US2022/020482 WO2022197758A1 (en) | 2021-03-17 | 2022-03-16 | Heteroaryl inhibitors of plasma kallikrein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024516073A JP2024516073A (ja) | 2024-04-12 |
| JP2024516073A5 JP2024516073A5 (https=) | 2025-03-25 |
| JPWO2022197758A5 true JPWO2022197758A5 (https=) | 2025-03-25 |
Family
ID=81328275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557140A Pending JP2024516073A (ja) | 2021-03-17 | 2022-03-16 | 血漿カリクレインのヘテロアリール阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240228488A1 (https=) |
| EP (2) | EP4585265A3 (https=) |
| JP (1) | JP2024516073A (https=) |
| KR (1) | KR20240004296A (https=) |
| CN (1) | CN117355521A (https=) |
| AU (1) | AU2022240596A1 (https=) |
| BR (1) | BR112023018619A2 (https=) |
| CA (1) | CA3208243A1 (https=) |
| MX (1) | MX2023011014A (https=) |
| WO (1) | WO2022197758A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200143376A (ko) | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도 |
| CN114667289B (zh) | 2019-09-18 | 2025-08-26 | 武田药品工业有限公司 | 杂芳基血浆激肽释放酶抑制剂 |
| EP4031547B1 (en) | 2019-09-18 | 2024-07-17 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof |
| BR112023018619A2 (pt) | 2021-03-17 | 2023-11-28 | Takeda Pharmaceuticals Co | Inibidores de heteroaril de calicreína plasmática |
| CN117396473A (zh) * | 2021-03-17 | 2024-01-12 | 武田药品工业株式会社 | 血浆激肽释放酶的咪唑并吡啶基抑制剂 |
| JP2025531158A (ja) * | 2022-09-21 | 2025-09-19 | 武田薬品工業株式会社 | シクロプロパンカルボン酸の合成 |
| KR20260029377A (ko) * | 2023-06-29 | 2026-03-04 | 테라닙 인코포레이티드 | 암 및 염증성 질환 치료에 사용하기 위한 이미다조[1,2-α]피리딘 화합물 및 그 화합물의 제조 방법 |
| CN117069662A (zh) * | 2023-10-17 | 2023-11-17 | 峰成医药科技(天津)有限公司 | 一种4,6-二氯-2-（二氟甲基）嘧啶的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| GB201421088D0 (en) * | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | New enzyme inhibitors |
| WO2016201052A1 (en) * | 2015-06-12 | 2016-12-15 | Global Blood Therapeutics, Inc. | Bridged bicyclic kallikrein inhibitors |
| KR20200143376A (ko) | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도 |
| BR112023018619A2 (pt) | 2021-03-17 | 2023-11-28 | Takeda Pharmaceuticals Co | Inibidores de heteroaril de calicreína plasmática |
-
2022
- 2022-03-16 BR BR112023018619A patent/BR112023018619A2/pt unknown
- 2022-03-16 MX MX2023011014A patent/MX2023011014A/es unknown
- 2022-03-16 KR KR1020237034887A patent/KR20240004296A/ko active Pending
- 2022-03-16 AU AU2022240596A patent/AU2022240596A1/en active Pending
- 2022-03-16 US US18/550,306 patent/US20240228488A1/en active Pending
- 2022-03-16 WO PCT/US2022/020482 patent/WO2022197758A1/en not_active Ceased
- 2022-03-16 EP EP25179074.7A patent/EP4585265A3/en active Pending
- 2022-03-16 EP EP22716137.9A patent/EP4308230A1/en active Pending
- 2022-03-16 CN CN202280022472.XA patent/CN117355521A/zh active Pending
- 2022-03-16 JP JP2023557140A patent/JP2024516073A/ja active Pending
- 2022-03-16 CA CA3208243A patent/CA3208243A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020525442A5 (https=) | ||
| JP6675316B2 (ja) | 開環メタセシス重合のための触媒及び方法 | |
| JP4344234B2 (ja) | タキソール増強剤化合物 | |
| JP2021524440A5 (https=) | ||
| JP2021518441A5 (https=) | ||
| JPWO2022197758A5 (https=) | ||
| JP2009526761A5 (https=) | ||
| TW200906829A (en) | 5,6-dihydro-1H-pyridin-2-one compounds | |
| JPWO2021055621A5 (https=) | ||
| JP2015532295A5 (https=) | ||
| RU2005102004A (ru) | Замещенные хинолины как антагонисты рецептора ccr5 | |
| ATE14423T1 (de) | Hydroxamsaeurederivate vom typ der mannich-basen mit verbesserter biologischer verfuegbarkeit von nicht-steroiden entzuendungshemmern, verfahren zur herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzung. | |
| BG60534B2 (bg) | Уреидо производни на поли-4-амино-2-карбокси-1-метилни съединения | |
| RU2015143676A (ru) | Модулятолры ship1 и относящиеся к ним способы | |
| RU2009136996A (ru) | Трициклические соединения, которые можно использовать для лечения нарушений, связанных с анормальным уровнем содержания железа в организме | |
| JP2017538689A5 (https=) | ||
| DE60220255T2 (de) | N-phenylarylsulfonamidverbindung, arzneimittel, das diese verbindung als wirkstoff enthält, zwischenprodukt für die verbindung und verfahren zu dessen herstellung | |
| JPWO2019236890A5 (https=) | ||
| RU2005135439A (ru) | Производные индена в качестве фармацевтических средств | |
| RU2007107494A (ru) | Трициклические производные инденопиррола как модуляторы серотининовых рецепторов, фармацевтическая композиция на их основе и способ лечения заболеваний, растройств и/или патологических состояний, связанных с необходимостью модуляции функции 5-нт2с рецепторов | |
| JP2008508365A5 (https=) | ||
| JP2010510216A5 (https=) | ||
| JPWO2019222468A5 (https=) | ||
| Ho et al. | 13C NMR spectra of polymers made by ring‐opening polymerization of optically active and racemic 5, 5‐dimethylbicyclo [2.2. 1] hept‐2‐ene using metathesis catalysts | |
| JPWO2022197763A5 (https=) |